Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.

@article{Nissen2010RosiglitazoneRA,
  title={Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.},
  author={Steven Evan Nissen and Kathy E Wolski},
  journal={Archives of internal medicine},
  year={2010},
  volume={170 14},
  pages={1191-1201}
}
CONTEXT Controversy regarding the effects of rosiglitazone therapy on myocardial infarction (MI) and cardiovascular (CV) mortality persists 3 years after a meta-analysis initially raised concerns about the use of this drug. OBJECTIVE To systematically review the effects of rosiglitazone therapy on MI and mortality (CV and all-cause). DATA SOURCES We searched MEDLINE, the Web site of the Food and Drug Administration, and the GlaxoSmithKline clinical trials registry for trials published… CONTINUE READING

From This Paper

Figures and tables from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 239 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Similar Papers

Loading similar papers…